Physician profile
Lynn W Driver
NPI 1306836143
$2,526.17
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2020: $289 · 2021: $453 · 2022: $760 · 2023: $401 · 2024: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $652.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $453.37 | 2019-2024 | Ubrelvy, Liletta, Lo Loestrin Fe |
| Aspira Women'S Health INC | $329.51 | 2022-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $265.22 | 2019-2024 | |
| Astellas Pharma US INC | $208.11 | 2019-2024 | Veozah |
| Organon LLC | $150.26 | 2021-2024 | Nexplanon |
| Avion Pharmaceuticals | $139.68 | 2019-2023 | Balcoltra |
| Coopersurgical, INC. | $133.28 | 2019-2024 | Paragard T 380a, Mara Console, Summit Doppler |
| Daiichi Sankyo INC. | $80.70 | 2019-2022 | |
| Exeltis, USA INC. | $76.40 | 2019-2023 | Slynd |
| Merck Sharp & Dohme LLC | $70.19 | 2019-2022 | |
| Channel Medsystems, INC. | $62.40 | 2022 | |
| Exact Sciences Corporation | $55.49 | 2023-2024 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $50.51 | 2019-2021 | |
| Pfizer INC. | $47.32 | 2021-2023 | |
| Becton, Dickinson and Company | $37.55 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $36.60 | 2022 | |
| Millicent US INC | $33.12 | 2022-2023 | Intrarosa, Femring |
| Biogen, INC. | $30.86 | 2024 | |
| Duchesnay USA Incorporated | $28.83 | 2019 | |
| Allergan, INC. | $24.77 | 2019 | |
| Vertical Pharmaceuticals, LLC | $24.50 | 2019-2020 | |
| Ethicon US, LLC | $21.40 | 2019 | |
| Shield Therapeutics INC | $18.13 | 2024 | |
| Agile Therapeutics, INC. | $16.12 | 2021 | |
| Endo Pharmaceuticals INC. | $14.93 | 2019 | |
| Amgen INC. | $14.49 | 2019 | |
| Mayne Pharma Commercial LLC | $13.61 | 2021 | |
| Medtronic, INC. | $13.60 | 2023 | Truclear |
| Seqirus USA INC | $13.09 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.02 | 2019 | |
| Sanofi Pasteur INC. | $12.74 | 2019 | |
| Evofem Biosciences, INC. | $12.60 | 2021 | |
| Olympus America INC. | $11.95 | 2022 | |
| Myovant Sciences INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lynn Driver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.